FNY Investment Advisers’s ResMed RMD Stock Holding History

FNY Investment Advisers’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-1,400	Closed	-$341K	–	890
2024 Q3	$341K	Sell	1,400 -7,100	-84%	-$1.59M	0.16%	122
2024 Q2	$1.63M	Buy	+8,500	New	+$1.72M	1.09%	22
2023 Q4	–	Sell	-34,200	Closed	-$5.06M	–	737
2023 Q3	$5.06M	Buy	34,200 +32,200	+1,610%	+$5.82M	3.01%	6
2023 Q2	$437K	Buy	+2,000	New	+$446K	0.55%	36
2021 Q4	–	Sell	-6,532	Closed	-$1.72M	–	775
2021 Q3	$1.72M	Buy	6,532 +2,802	+75%	+$766K	0.8%	39
2021 Q2	$919K	Sell	3,730 -2,770	-43%	-$582K	0.37%	69
2021 Q1	$1.26M	Buy	+6,500	New	+$1.3M	0.47%	49
2020 Q4	–	Sell	-64	Closed	-$10K	–	889
2020 Q3	$10K	Buy	+64	New	+$11.8K	﹤0.01%	331
2019 Q2	–	Sell	-17,384	Closed	-$1.81M	–	1112
2019 Q1	$1.81M	Buy	+17,384	New	+$1.79M	0.62%	29

Other funds holding RMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

FNY Investment Advisers's RMD Position: Q4 2024 in Review

FNY Investment Advisers sold out of ResMed (RMD) in Q4 2024, closing a stake of 1,400 shares — an estimated $341K sold.

FNY Investment Advisers first reported a position in RMD in Q1 2019 and held it in 9 quarters. The position peaked at $5.06M in Q3 2023. 872 funds tracked by Wall St. Rank hold RMD as of Q4 2024.

FNY Investment Advisers reported no remaining ResMed position as of Q4 2024 after selling out during the quarter.
FNY Investment Advisers sold 1,400 ResMed shares in Q4 2024, an estimated $341K.
FNY Investment Advisers first reported a position in ResMed in Q1 2019 and held it in 9 quarters.
FNY Investment Advisers's ResMed position peaked at $5.06M in Q3 2023.
872 funds tracked by Wall St. Rank held ResMed as of Q4 2024.

Based on FNY Investment Advisers's 13F filing for Q4 2024, filed 13 Jan 2025.